Patient characteristics
. | All . | Methylated . | Unmethylated . | P . |
---|---|---|---|---|
101 | 63 | 38 | ||
Cytogenetic risk | ||||
Favorable | 17 | 6 | 11 | |
Intermediate | 68 | 49 | 19 | |
Poor | 12 | 7 | 5 | .017 |
Missing | 4 | 1 | 3 | |
Leukocytes, ×109/L | ||||
< 10 | 29 | 18 | 11 | |
10-19.9 | 22 | 12 | 10 | |
20-49.9 | 16 | 7 | 9 | |
50-99.9 | 18 | 14 | 4 | |
> 100 | 12 | 10 | 2 | .134 |
Missing | 4 | 2 | 2 | |
Sex | ||||
Female | 45 | 30 | 15 | |
Male | 56 | 33 | 23 | .536 |
Age, y | 56.87 (SD 16.3) | 57.8 (SD 15.1) | 55.33 (SD 18.3) | |
< 60 | 50 | 30 | 20 | |
≥ 60 | 51 | 33 | 18 | .684 |
. | All . | Methylated . | Unmethylated . | P . |
---|---|---|---|---|
101 | 63 | 38 | ||
Cytogenetic risk | ||||
Favorable | 17 | 6 | 11 | |
Intermediate | 68 | 49 | 19 | |
Poor | 12 | 7 | 5 | .017 |
Missing | 4 | 1 | 3 | |
Leukocytes, ×109/L | ||||
< 10 | 29 | 18 | 11 | |
10-19.9 | 22 | 12 | 10 | |
20-49.9 | 16 | 7 | 9 | |
50-99.9 | 18 | 14 | 4 | |
> 100 | 12 | 10 | 2 | .134 |
Missing | 4 | 2 | 2 | |
Sex | ||||
Female | 45 | 30 | 15 | |
Male | 56 | 33 | 23 | .536 |
Age, y | 56.87 (SD 16.3) | 57.8 (SD 15.1) | 55.33 (SD 18.3) | |
< 60 | 50 | 30 | 20 | |
≥ 60 | 51 | 33 | 18 | .684 |